The purpose of the present invention is to provide a novel compound which has an anti-fungal activity on pathogenic fungi including fungi belonging to the genus
Candida
, the genus
Aspergillus
and the genus
Trichophyton
and is useful as a medicinal agent. A compound represented by formula (I) (wherein A
1
represents a nitrogen atom or a group represented by formula CR
6
; A
2
and A
3
are the same as or different from each other and independently represent a nitrogen atom or a group represented by formula CH; R
1
represents an aryl group which may be substituted by 1 to 5 substituents independently selected from a substituent group (2) or the like; R
2
and R
3
are the same as or different from each other and independently represent a hydrogen atom, a halogen atom, a C
1-6
alkyl group, a C
1-6
haloalkyl group or a C
1-6
alkoxy group; and R
4
and R
5
are the same as or different from each other and independently represent a hydrogen atom, a C
1-6
haloalkyl group, a C
1-6
alkyl group or the like) or a salt thereof is useful as an anti-fungal agent.
Disclosed are compounds of Formula (I), or pharmaceutically acceptable salts thereof, wherein Z, X, Q and R1 are as described in this application, and methods of using the compounds in the treatment of cancer.
In the field of tissue engineering, the development of novel switchable cell growth scaffolds and triggered substrate surfaces is desirable for manipulating detachment of cells. In this paper, two kinds of pH-responsive C2-cyclohexane based cell scaffold biomaterials (G1 and G2) have been designed and synthesized. The highlight is that they can induce detachment of cells from material's surface by slightly reducing the pH of culture medium in an acceptable range. The abilities to culture cells on hydrogel scaffolds and guide cells to detach without proteolytic enzyme treatment are very useful for their development in various biomedical applications.